MIDODRINE HYDROCHLORIDE

MIDODRINE HYDROCHLORIDE was reported 4486 times

MIDODRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACCESSORY MUSCLE 3 0.5000
1 CARDIAC PACEMAKER EVALUATION 6 0.2609
2 DIALYSIS HYPOTENSION 8 0.0808
3 SERUM AMYLOID A PROTEIN INCREASED 10 0.0645
4 BURKHOLDERIA TEST POSITIVE 6 0.0484
5 DEVICE WIRELESS COMMUNICATION ISSUE 10 0.0386
6 INFUSION SITE INJURY 6 0.0341
7 SUPINE HYPERTENSION 6 0.0317
8 AUTOIMMUNE NEUROPATHY 4 0.0310
9 SKIN FIBROSIS 14 0.0289
10 CATHETER SITE INDURATION 4 0.0207
11 DEVICE MAINTENANCE ISSUE 12 0.0204
12 PATIENT DISSATISFACTION WITH DEVICE 5 0.0198
13 INFUSION SITE WARMTH 24 0.0196
14 VASCULAR DEVICE OCCLUSION 6 0.0177
15 INFUSION SITE NODULE 16 0.0166
16 INFUSION SITE ABSCESS 8 0.0159
17 DEVICE INFUSION ISSUE 39 0.0157
18 INFUSION SITE INDURATION 23 0.0155
19 INFUSION SITE INFECTION 36 0.0155
20 JOINT CONTRACTURE 16 0.0149
21 INFUSION SITE HAEMORRHAGE 47 0.0143
22 INFUSION SITE SWELLING 89 0.0141
23 EXTREMITY CONTRACTURE 9 0.0141
24 FEEDING TUBE USER 5 0.0137
25 INFUSION SITE CELLULITIS 7 0.0133
26 INFUSION SITE IRRITATION 17 0.0132
27 TRICUSPID VALVE DISEASE 5 0.0125
28 SKIN INDURATION 26 0.0125
29 INFUSION SITE PAIN 159 0.0123
30 CATHETER SITE BRUISE 4 0.0121
31 IODINE ALLERGY 4 0.0120
32 CATHETER SITE IRRITATION 4 0.0120
33 INFUSION SITE ERYTHEMA 101 0.0120
34 WRONG PATIENT 6 0.0120
35 NEPHROGENIC SYSTEMIC FIBROSIS 36 0.0119
36 CATHETER SITE DISCHARGE 13 0.0116
37 HYPERVOLAEMIA 57 0.0115
38 INFUSION SITE DISCHARGE 20 0.0114
39 MULTIPLE SYSTEM ATROPHY 4 0.0114
40 INFUSION SITE INFLAMMATION 8 0.0113
41 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 15 0.0111
42 CATHETER SITE SWELLING 10 0.0107
43 ORTHOSTATIC INTOLERANCE 7 0.0097
44 SUTURE RUPTURE 6 0.0087
45 INFUSION SITE MASS 9 0.0083
46 DEEP BRAIN STIMULATION 5 0.0083
47 INFUSION SITE DISCOLOURATION 7 0.0080
48 AUTONOMIC NEUROPATHY 8 0.0079
49 SKIN HYPERTROPHY 22 0.0078
50 AMMONIA ABNORMAL 3 0.0074
51 INFUSION SITE REACTION 22 0.0074
52 STOMA SITE IRRITATION 4 0.0074
53 VASCULAR DEVICE INFECTION 33 0.0073
54 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 4 0.0071
55 FACIAL DISCOMFORT 5 0.0071
56 INFUSION SITE PRURITUS 22 0.0070
57 INFUSION SITE DISCOMFORT 7 0.0068
58 STOMA SITE INFLAMMATION 5 0.0067
59 DIZZINESS EXERTIONAL 5 0.0066
60 DRY GANGRENE 4 0.0063
61 WRONG PATIENT RECEIVED PRODUCT 18 0.0061
62 CATHETER SITE ERYTHEMA 13 0.0061
63 INFUSION SITE BRUISING 13 0.0060
64 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 6 0.0060
65 LYMPHOCYTE PERCENTAGE DECREASED 8 0.0060
66 HYPERTENSIVE EMERGENCY 7 0.0059
67 MAST CELL ACTIVATION SYNDROME 8 0.0057
68 FUNGAL OESOPHAGITIS 4 0.0057
69 SUTURE RELATED COMPLICATION 4 0.0057
70 CATHETER SITE HAEMORRHAGE 14 0.0056
71 IMMUNISATION REACTION 4 0.0056
72 VASCULAR INJURY 8 0.0055
73 HAEMATOLOGICAL INFECTION 13 0.0053
74 FIBROSIS 16 0.0052
75 ON AND OFF PHENOMENON 28 0.0050
76 ARTERIOVENOUS FISTULA SITE COMPLICATION 3 0.0050
77 REDUCED FACIAL EXPRESSION 5 0.0049
78 SEASONAL ALLERGY 69 0.0049
79 DEVICE POWER SOURCE ISSUE 14 0.0048
80 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
81 DEVICE CONNECTION ISSUE 10 0.0047
82 PRODUCT ADMINISTRATION INTERRUPTED 37 0.0047
83 DRUG TOLERANCE DECREASED 13 0.0046
84 CATHETER SITE PAIN 12 0.0046
85 CATHETER SITE PRURITUS 4 0.0046
86 DEMENTIA WITH LEWY BODIES 5 0.0045
87 FREEZING PHENOMENON 16 0.0043
88 DERMATITIS CONTACT 48 0.0042
89 PATIENT DISSATISFACTION WITH TREATMENT 8 0.0041
90 DUST ALLERGY 4 0.0041
91 LARGE INTESTINE INFECTION 5 0.0041
92 SKIN TIGHTNESS 19 0.0040
93 DEVICE ALARM ISSUE 7 0.0039
94 HALLUCINATIONS, MIXED 16 0.0038
95 SINUSITIS BACTERIAL 4 0.0038
96 ORTHOSTATIC HYPOTENSION 66 0.0038
97 OXYGEN CONSUMPTION INCREASED 9 0.0038
98 PILOERECTION 4 0.0037
99 INFUSION SITE RASH 5 0.0036
100 CARDIAC AMYLOIDOSIS 4 0.0036
101 DIABETIC METABOLIC DECOMPENSATION 5 0.0036
102 BLOOD LOSS ANAEMIA 8 0.0035
103 HAEMOGLOBIN INCREASED 16 0.0035
104 PNEUMONIA INFLUENZAL 4 0.0034
105 NOCTURNAL DYSPNOEA 4 0.0031
106 INJECTION SITE INFECTION 10 0.0030
107 OESOPHAGEAL HAEMORRHAGE 4 0.0030
108 DEVICE RELATED SEPSIS 6 0.0030
109 CATHETER SITE INFECTION 11 0.0029
110 AKINESIA 6 0.0029
111 SLOW SPEECH 7 0.0029
112 HYPERKINESIA 6 0.0028
113 CARDIAC ABLATION 5 0.0028
114 HYPERPARATHYROIDISM SECONDARY 7 0.0028
115 NOROVIRUS INFECTION 4 0.0028
116 PULMONARY ARTERIAL HYPERTENSION 40 0.0028
117 STOMA SITE PAIN 4 0.0027
118 DIZZINESS POSTURAL 26 0.0027
119 RENAL FAILURE CHRONIC 20 0.0026
120 PULMONARY HYPERTENSION 54 0.0026
121 GENERALISED OEDEMA 31 0.0025
122 PRODUCT LEAKAGE 14 0.0025
123 EYELID PAIN 5 0.0025
124 PULMONARY ARTERIAL PRESSURE INCREASED 4 0.0025
125 CAPILLARY LEAK SYNDROME 5 0.0024
126 DYSPNOEA AT REST 7 0.0024
127 RESUSCITATION 4 0.0024
128 INCORRECT DRUG ADMINISTRATION RATE 10 0.0023
129 HALLUCINATION, VISUAL 49 0.0023
130 OCULAR ICTERUS 10 0.0023
131 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
132 CALCIPHYLAXIS 4 0.0022
133 PNEUMONIA KLEBSIELLA 4 0.0022
134 CEREBROSPINAL FLUID LEAKAGE 4 0.0022
135 CATHETER PLACEMENT 4 0.0022
136 INJECTION SITE CELLULITIS 4 0.0022
137 MALNUTRITION 24 0.0021
138 STOMA SITE ERYTHEMA 4 0.0021
139 ENDOTRACHEAL INTUBATION 6 0.0021
140 COMPLICATION ASSOCIATED WITH DEVICE 31 0.0021
141 DEVICE OCCLUSION 30 0.0021
142 FAILURE TO THRIVE 11 0.0021
143 HEPATIC MASS 4 0.0021
144 PULMONARY PAIN 6 0.0021
145 HYPOTENSION 408 0.0020
146 CARTILAGE INJURY 5 0.0020
147 AZOTAEMIA 8 0.0020
148 RETINAL ARTERY OCCLUSION 5 0.0020
149 SKIN HYPERPIGMENTATION 16 0.0019
150 INSURANCE ISSUE 28 0.0018
151 RESPIRATORY TRACT CONGESTION 29 0.0018
152 BLOOD PRESSURE ABNORMAL 36 0.0018
153 REHABILITATION THERAPY 7 0.0018
154 DELUSION 28 0.0018
155 OXYGEN SATURATION DECREASED 101 0.0018
156 BLOOD PRESSURE DECREASED 118 0.0018
157 OXYGEN SATURATION ABNORMAL 5 0.0018
158 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
159 AORTIC STENOSIS 6 0.0017
160 RESPIRATORY TRACT INFECTION VIRAL 4 0.0017
161 BRADYKINESIA 10 0.0017
162 INGROWING NAIL 4 0.0017
163 HAEMORRHAGIC DIATHESIS 6 0.0017
164 FOOD POISONING 9 0.0017
165 SOMNAMBULISM 11 0.0017
166 DYSPNOEA EXERTIONAL 63 0.0017
167 PULSE ABNORMAL 4 0.0017
168 MULTIPLE ALLERGIES 13 0.0017
169 CARDIAC FAILURE ACUTE 11 0.0016
170 GASTROINTESTINAL TUBE INSERTION 4 0.0016
171 PULMONARY FUNCTION TEST DECREASED 7 0.0016
172 FLUID RETENTION 81 0.0016
173 RIGHT VENTRICULAR FAILURE 11 0.0016
174 ABDOMINAL INFECTION 4 0.0016
175 RALES 9 0.0015
176 HEPATIC NEOPLASM 5 0.0015
177 NEPHROGENIC ANAEMIA 7 0.0015
178 PRODUCT DISTRIBUTION ISSUE 14 0.0015
179 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
180 OBSTRUCTION 6 0.0015
181 HALLUCINATION 113 0.0015
182 ENURESIS 6 0.0015
183 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
184 SKIN LACERATION 16 0.0015
185 UNINTENTIONAL MEDICAL DEVICE REMOVAL 17 0.0015
186 NONSPECIFIC REACTION 8 0.0015
187 HUMERUS FRACTURE 7 0.0015
188 ATELECTASIS 14 0.0014
189 INFUSION SITE EXTRAVASATION 9 0.0014
190 BLOOD CREATININE ABNORMAL 5 0.0014
191 LUNG CONSOLIDATION 4 0.0014
192 PURULENT DISCHARGE 6 0.0014
193 PNEUMATOSIS INTESTINALIS 4 0.0014
194 BLOOD POTASSIUM DECREASED 42 0.0014
195 PAIN IN JAW 39 0.0014
196 SCLERODERMA 5 0.0014
197 IMMOBILE 6 0.0014
198 DEVICE KINK 5 0.0014
199 BACTERIAL TEST POSITIVE 3 0.0013
200 JOINT RANGE OF MOTION DECREASED 18 0.0013
201 ATYPICAL PNEUMONIA 4 0.0013
202 ANAL INCONTINENCE 12 0.0013
203 CENTRAL VENOUS CATHETERISATION 4 0.0013
204 GASTRIC INFECTION 5 0.0013
205 SKIN PLAQUE 11 0.0013
206 INJECTION SITE DISCHARGE 7 0.0013
207 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
208 HAEMORRHAGIC STROKE 10 0.0013
209 PRESYNCOPE 31 0.0013
210 RESPIRATORY RATE DECREASED 4 0.0013
211 INTESTINAL ISCHAEMIA 7 0.0013
212 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
213 IDIOPATHIC PULMONARY FIBROSIS 5 0.0013
214 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
215 ASCITES 37 0.0013
216 MUSCLE RIGIDITY 15 0.0013
217 IMPAIRED GASTRIC EMPTYING 17 0.0012
218 WEIGHT FLUCTUATION 13 0.0012
219 CHOLECYSTITIS ACUTE 7 0.0012
220 HEAD INJURY 39 0.0012
221 HAEMORRHOIDAL HAEMORRHAGE 6 0.0012
222 DECUBITUS ULCER 10 0.0012
223 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
224 PERIPHERAL ISCHAEMIA 5 0.0012
225 BREATH SOUNDS ABNORMAL 6 0.0012
226 HOSPICE CARE 12 0.0012
227 LEG AMPUTATION 5 0.0012
228 BRAIN FOG 19 0.0012
229 BLOOD PRESSURE FLUCTUATION 29 0.0012
230 PROTEIN URINE PRESENT 6 0.0012
231 THERAPY NON-RESPONDER 54 0.0012
232 HYPOVOLAEMIA 7 0.0012
233 DEVICE FAILURE 18 0.0012
234 EPISTAXIS 88 0.0012
235 AORTIC VALVE INCOMPETENCE 5 0.0012
236 PERICARDIAL EFFUSION 27 0.0012
237 DEVICE OPERATIONAL ISSUE 5 0.0012
238 GANGRENE 7 0.0012
239 SYNCOPE 114 0.0011
240 WHEELCHAIR USER 5 0.0011
241 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
242 ELECTROLYTE IMBALANCE 13 0.0011
243 DEVICE PLACEMENT ISSUE 4 0.0011
244 BRUXISM 6 0.0011
245 FACIAL BONES FRACTURE 4 0.0011
246 SCAR 19 0.0011
247 URINE ABNORMALITY 5 0.0011
248 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
249 BLOOD IRON DECREASED 13 0.0011
250 SUBARACHNOID HAEMORRHAGE 11 0.0011
251 SLUGGISHNESS 11 0.0011
252 DEFORMITY 10 0.0011
253 TIBIA FRACTURE 5 0.0011
254 DEVICE DISLOCATION 46 0.0011
255 PARANASAL SINUS DISCOMFORT 4 0.0011
256 SMALL INTESTINAL OBSTRUCTION 13 0.0011
257 APPETITE DISORDER 7 0.0011
258 BLOOD MAGNESIUM DECREASED 9 0.0010
259 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
260 FOOD ALLERGY 8 0.0010
261 ULCER HAEMORRHAGE 7 0.0010
262 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
263 ILLNESS 106 0.0010
264 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
265 PROSTATOMEGALY 4 0.0010
266 PLEURISY 6 0.0010
267 CARDIAC PACEMAKER INSERTION 6 0.0010
268 PRODUCTIVE COUGH 48 0.0010
269 PULMONARY OEDEMA 45 0.0010
270 CEREBRAL ATROPHY 4 0.0010
271 FLUID INTAKE REDUCED 5 0.0010
272 LOSS OF CONSCIOUSNESS 127 0.0010
273 INTENTIONAL DOSE OMISSION 28 0.0010
274 HYPOXIA 34 0.0010
275 THERAPY PARTIAL RESPONDER 15 0.0010
276 SLEEP TERROR 4 0.0009
277 SENSITIVE SKIN 7 0.0009
278 HYPERPYREXIA 4 0.0009
279 HYPERSOMNIA 27 0.0009
280 POOR PERIPHERAL CIRCULATION 4 0.0009
281 POST PROCEDURAL COMPLICATION 18 0.0009
282 DYSKINESIA 38 0.0009
283 COMPRESSION FRACTURE 5 0.0009
284 HIP FRACTURE 30 0.0009
285 FALL 310 0.0009
286 UNRESPONSIVE TO STIMULI 24 0.0009
287 PARANOIA 16 0.0009
288 INCOHERENT 6 0.0009
289 RESPIRATORY TRACT INFECTION 24 0.0009
290 PLEURAL EFFUSION 56 0.0009
291 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
292 KIDNEY INFECTION 18 0.0009
293 DIALYSIS 13 0.0009
294 DIVERTICULUM INTESTINAL 4 0.0009
295 BOWEL MOVEMENT IRREGULARITY 7 0.0009
296 CHOKING SENSATION 5 0.0009
297 BLOOD CREATINE INCREASED 4 0.0009
298 CATHETERISATION CARDIAC 4 0.0009
299 BLOOD SODIUM DECREASED 17 0.0009
300 ILEUS PARALYTIC 4 0.0009
301 HYPOKINESIA 13 0.0009
302 TORSADE DE POINTES 7 0.0009
303 SKIN INFECTION 10 0.0009
304 RETCHING 19 0.0009
305 IRON DEFICIENCY 4 0.0009
306 POSTOPERATIVE WOUND INFECTION 6 0.0009
307 ACUTE RESPIRATORY FAILURE 17 0.0009
308 MITRAL VALVE INCOMPETENCE 10 0.0009
309 TRICUSPID VALVE INCOMPETENCE 7 0.0009
310 PNEUMONIA ASPIRATION 22 0.0009
311 GRANULOCYTOPENIA 5 0.0009
312 ATRIAL FLUTTER 7 0.0009
313 ABDOMINAL HERNIA 4 0.0009
314 URINARY TRACT INFECTION 149 0.0009
315 HYPERTONIA 5 0.0009
316 PNEUMONIA BACTERIAL 8 0.0009
317 ISCHAEMIA 4 0.0009
318 SKIN ATROPHY 5 0.0009
319 EXERCISE TOLERANCE DECREASED 5 0.0009
320 LOCALISED OEDEMA 4 0.0009
321 MOBILITY DECREASED 62 0.0009
322 POST PROCEDURAL INFECTION 7 0.0009
323 DEVICE USE ISSUE 15 0.0009
324 HEPATIC ENCEPHALOPATHY 8 0.0009
325 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
326 COVID-19 PNEUMONIA 10 0.0008
327 SKIN ABRASION 4 0.0008
328 MUSCULOSKELETAL CHEST PAIN 13 0.0008
329 ODYNOPHAGIA 5 0.0008
330 ENTEROCOCCAL INFECTION 4 0.0008
331 PULMONARY THROMBOSIS 9 0.0008
332 FLUID OVERLOAD 12 0.0008
333 END STAGE RENAL DISEASE 15 0.0008
334 ASPIRATION 9 0.0008
335 CYSTITIS 26 0.0008
336 CARDIOMEGALY 10 0.0008
337 STAPHYLOCOCCAL SEPSIS 4 0.0008
338 COUGH 226 0.0008
339 OCULAR DISCOMFORT 9 0.0008
340 SEPSIS 89 0.0008
341 SWELLING OF EYELID 5 0.0008
342 HEAD DISCOMFORT 14 0.0008
343 INTERNAL HAEMORRHAGE 9 0.0008
344 AMMONIA INCREASED 4 0.0008
345 THIRST 14 0.0008
346 DEVICE PHYSICAL PROPERTY ISSUE 6 0.0008
347 INITIAL INSOMNIA 8 0.0008
348 DEVICE RELATED INFECTION 12 0.0008
349 GENERAL PHYSICAL HEALTH DETERIORATION 90 0.0008
350 ATRIOVENTRICULAR BLOCK 6 0.0008
351 GASTROENTERITIS VIRAL 14 0.0008
352 CONCUSSION 6 0.0008
353 PELVIC FRACTURE 6 0.0008
354 SUBDURAL HAEMATOMA 11 0.0008
355 HEART RATE INCREASED 76 0.0008
356 OEDEMA PERIPHERAL 93 0.0008
357 PRODUCT USE COMPLAINT 12 0.0008
358 RESPIRATORY DISTRESS 21 0.0008
359 SENSITIVITY TO WEATHER CHANGE 4 0.0008
360 DYSGRAPHIA 5 0.0008
361 IRON DEFICIENCY ANAEMIA 7 0.0008
362 DEHYDRATION 100 0.0007
363 GAIT INABILITY 25 0.0007
364 HEREDITARY ANGIOEDEMA 8 0.0007
365 CARDIOMYOPATHY 11 0.0007
366 STENT PLACEMENT 6 0.0007
367 LIMB DISCOMFORT 23 0.0007
368 URINARY INCONTINENCE 22 0.0007
369 WRONG PRODUCT ADMINISTERED 5 0.0007
370 BLOOD POTASSIUM INCREASED 12 0.0007
371 CONFUSIONAL STATE 119 0.0007
372 LIMB INJURY 20 0.0007
373 THROAT IRRITATION 33 0.0007
374 CHEST PAIN 136 0.0007
375 ABNORMAL LOSS OF WEIGHT 5 0.0007
376 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
377 POLYURIA 6 0.0007
378 FAECALOMA 4 0.0007
379 HYPERKERATOSIS 4 0.0007
380 CARDIAC FAILURE CONGESTIVE 58 0.0007
381 NERVE INJURY 8 0.0007
382 URINARY RETENTION 24 0.0007
383 SECRETION DISCHARGE 9 0.0007
384 AUTOIMMUNE DISORDER 7 0.0007
385 BALANCE DISORDER 62 0.0007
386 ANGIOPATHY 4 0.0007
387 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
388 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
389 BLOOD TEST ABNORMAL 10 0.0007
390 MUSCLE ATROPHY 9 0.0007
391 WEIGHT DECREASED 198 0.0007
392 HAEMATOCRIT DECREASED 14 0.0007
393 EATING DISORDER 15 0.0007
394 PERONEAL NERVE PALSY 4 0.0007
395 ABSCESS LIMB 3 0.0007
396 CYANOSIS 11 0.0007
397 CARDIOGENIC SHOCK 10 0.0007
398 POOR QUALITY SLEEP 15 0.0007
399 MUSCLE STRAIN 6 0.0007
400 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
401 DYSPNOEA 390 0.0007
402 BEDRIDDEN 9 0.0007
403 HEART RATE DECREASED 24 0.0007
404 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
405 SARS-COV-2 TEST POSITIVE 9 0.0007
406 RIB FRACTURE 14 0.0007
407 ABDOMINAL ABSCESS 3 0.0007
408 HAEMARTHROSIS 6 0.0007
409 GOUT 12 0.0007
410 DEVICE LEAKAGE 29 0.0007
411 EAR PAIN 13 0.0007
412 SYMPTOM RECURRENCE 4 0.0007
413 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
414 DEVICE USE ERROR 23 0.0007
415 INJECTION SITE VESICLES 4 0.0007
416 RENAL PAIN 7 0.0007
417 ADRENAL INSUFFICIENCY 8 0.0007
418 ACIDOSIS 5 0.0007
419 PROCEDURAL COMPLICATION 5 0.0007
420 UROSEPSIS 6 0.0006
421 DIZZINESS 324 0.0006
422 ATRIAL FIBRILLATION 63 0.0006
423 SCOLIOSIS 4 0.0006
424 OEDEMA 35 0.0006
425 OLIGURIA 4 0.0006
426 COGNITIVE DISORDER 30 0.0006
427 DIARRHOEA HAEMORRHAGIC 6 0.0006
428 PNEUMONIA 207 0.0006
429 MUSCULOSKELETAL DISCOMFORT 11 0.0006
430 EAR INFECTION 17 0.0006
431 HEPATIC CIRRHOSIS 12 0.0006
432 COVID-19 112 0.0006
433 HOSPITALISATION 98 0.0006
434 MULTIPLE INJURIES 4 0.0006
435 PALPITATIONS 74 0.0006
436 DISORIENTATION 25 0.0006
437 NASAL DISCOMFORT 5 0.0006
438 SPEECH DISORDER 33 0.0006
439 SLEEP APNOEA SYNDROME 12 0.0006
440 ULCER 10 0.0006
441 MIGRAINE 60 0.0006
442 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
443 SOMNOLENCE 126 0.0006
444 GASTROINTESTINAL DISORDER 56 0.0006
445 HEADACHE 391 0.0006
446 ABDOMINAL DISTENSION 65 0.0006
447 BRADYCARDIA 33 0.0006
448 SINUS BRADYCARDIA 6 0.0006
449 EYE PAIN 35 0.0006
450 EYE INFECTION 7 0.0006
451 CARDIAC FLUTTER 4 0.0006
452 SCAB 7 0.0006
453 NASAL CONGESTION 36 0.0006
454 DECREASED APPETITE 142 0.0006
455 CARDIAC FAILURE 49 0.0006
456 PRODUCT PREPARATION ISSUE 4 0.0006
457 HAEMOPTYSIS 17 0.0006
458 ANHEDONIA 16 0.0006
459 STAPHYLOCOCCAL INFECTION 20 0.0006
460 VIRAL INFECTION 20 0.0006
461 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
462 TERMINAL STATE 4 0.0006
463 SEPTIC SHOCK 26 0.0006
464 POST-TRAUMATIC STRESS DISORDER 4 0.0006
465 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
466 LUNG DISORDER 29 0.0006
467 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
468 DYSPHAGIA 56 0.0006
469 BACTERIAL INFECTION 11 0.0006
470 POOR VENOUS ACCESS 6 0.0006
471 DROOLING 4 0.0006
472 PRODUCT DOSE OMISSION ISSUE 170 0.0006
473 SKIN SWELLING 5 0.0006
474 HEART RATE IRREGULAR 13 0.0006
475 GASTROINTESTINAL HAEMORRHAGE 48 0.0006
476 DEMENTIA 16 0.0006
477 LOWER LIMB FRACTURE 11 0.0006
478 JOINT STIFFNESS 15 0.0006
479 FUNGAL INFECTION 19 0.0006
480 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
481 GROIN PAIN 5 0.0006
482 UNEVALUABLE EVENT 43 0.0006
483 HAND FRACTURE 4 0.0006
484 TREMOR 93 0.0006
485 GASTROINTESTINAL INFECTION 5 0.0006
486 GRAFT VERSUS HOST DISEASE 4 0.0006
487 CELLULITIS 28 0.0006
488 PANIC REACTION 4 0.0006
489 OSTEOMYELITIS 10 0.0006
490 PERIPHERAL SWELLING 85 0.0006
491 FAECES SOFT 4 0.0005
492 SPINAL FRACTURE 11 0.0005
493 DIARRHOEA 353 0.0005
494 RESTLESSNESS 20 0.0005
495 VENTRICULAR TACHYCARDIA 9 0.0005
496 PRODUCT ADMINISTRATION ERROR 11 0.0005
497 SKIN DISCOLOURATION 25 0.0005
498 FEEDING DISORDER 11 0.0005
499 TACHYCARDIA 48 0.0005
500 COAGULOPATHY 9 0.0005
501 ASTHENIA 203 0.0005
502 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
503 ARTHROPOD BITE 4 0.0005
504 FEELING COLD 15 0.0005
505 BLOOD UREA INCREASED 9 0.0005
506 NECK PAIN 30 0.0005
507 MUSCULAR WEAKNESS 61 0.0005
508 NEURALGIA 13 0.0005
509 FISTULA 6 0.0005
510 CANDIDA INFECTION 9 0.0005
511 PHOTOPHOBIA 10 0.0005
512 FLUSHING 54 0.0005
513 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
514 POLLAKIURIA 22 0.0005
515 FOOT FRACTURE 10 0.0005
516 SPUTUM DISCOLOURED 5 0.0005
517 SINUSITIS 54 0.0005
518 BRONCHITIS 39 0.0005
519 CHOLECYSTECTOMY 6 0.0005
520 FEELING JITTERY 10 0.0005
521 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
522 GASTRIC HAEMORRHAGE 6 0.0005
523 CHEST DISCOMFORT 53 0.0005
524 DYSTONIA 10 0.0005
525 TACHYPNOEA 7 0.0005
526 HYPOALBUMINAEMIA 4 0.0005
527 DEVICE INFORMATION OUTPUT ISSUE 4 0.0005
528 DYSSTASIA 15 0.0005
529 DEVICE ISSUE 46 0.0005
530 HAEMORRHOIDS 10 0.0005
531 SURGERY 30 0.0005
532 INFECTION 74 0.0005
533 NAUSEA 403 0.0005
534 CONTUSION 49 0.0005
535 BACTERAEMIA 6 0.0005
536 SINUS DISORDER 10 0.0005
537 DYSARTHRIA 19 0.0005
538 BLOOD ALBUMIN DECREASED 4 0.0005
539 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
540 RENAL CYST 4 0.0005
541 INABILITY TO AFFORD MEDICATION 5 0.0005
542 HYPOMAGNESAEMIA 7 0.0005
543 CARDIO-RESPIRATORY ARREST 21 0.0005
544 HAEMATOMA 13 0.0005
545 BRAIN INJURY 5 0.0005
546 MIOSIS 4 0.0005
547 TOOTHACHE 9 0.0005
548 OROPHARYNGEAL PAIN 46 0.0005
549 FULL BLOOD COUNT DECREASED 10 0.0005
550 NOCTURIA 6 0.0005
551 RENAL DISORDER 23 0.0005
552 SNEEZING 11 0.0005
553 VOMITING 229 0.0005
554 SPINAL OPERATION 6 0.0005
555 PRODUCT AVAILABILITY ISSUE 11 0.0005
556 MUSCLE INJURY 4 0.0005
557 MIDDLE INSOMNIA 9 0.0005
558 HAEMOGLOBIN DECREASED 49 0.0005
559 DERMATITIS ALLERGIC 6 0.0005
560 AGITATION 35 0.0005
561 FLATULENCE 27 0.0005
562 INFLUENZA 53 0.0005
563 SENSATION OF FOREIGN BODY 4 0.0005
564 PSYCHOTIC DISORDER 14 0.0005
565 FEELING HOT 29 0.0005
566 INCONTINENCE 5 0.0005
567 CARDIAC ARREST 39 0.0005
568 THROMBOSIS 38 0.0005
569 INJECTION SITE IRRITATION 6 0.0005
570 HAEMATOCHEZIA 26 0.0005
571 IMMUNODEFICIENCY 7 0.0005
572 HYPOPHAGIA 12 0.0005
573 VITAMIN D DECREASED 4 0.0005
574 MOVEMENT DISORDER 15 0.0005
575 CARDIAC OPERATION 4 0.0005
576 EXPOSURE VIA SKIN CONTACT 12 0.0005
577 MULTI-ORGAN FAILURE 8 0.0005
578 CARDIAC MURMUR 4 0.0005
579 DYSPHONIA 27 0.0005
580 DELIRIUM 16 0.0005
581 RASH MACULAR 16 0.0005
582 URINE OUTPUT DECREASED 4 0.0005
583 WOUND INFECTION 5 0.0005
584 BLOOD CALCIUM INCREASED 4 0.0005
585 NASOPHARYNGITIS 84 0.0005
586 ORAL CANDIDIASIS 6 0.0005
587 PULMONARY CONGESTION 6 0.0005
588 LOCALISED INFECTION 11 0.0005
589 TOOTH FRACTURE 5 0.0005
590 HYPERTENSION 96 0.0005
591 ANKLE FRACTURE 7 0.0005
592 GALLBLADDER DISORDER 8 0.0004
593 FEELING ABNORMAL 107 0.0004
594 MUSCULOSKELETAL STIFFNESS 39 0.0004
595 BLOOD PRESSURE INCREASED 68 0.0004
596 PAIN IN EXTREMITY 131 0.0004
597 HEAVY MENSTRUAL BLEEDING 4 0.0004
598 GAIT DISTURBANCE 85 0.0004
599 SINUS CONGESTION 6 0.0004
600 THROAT TIGHTNESS 12 0.0004
601 ARRHYTHMIA 21 0.0004
602 ANXIETY 126 0.0004
603 SCIATICA 7 0.0004
604 TREATMENT NONCOMPLIANCE 24 0.0004
605 EXOSTOSIS 4 0.0004
606 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
607 INCREASED TENDENCY TO BRUISE 4 0.0004
608 LETHARGY 25 0.0004
609 NIGHT SWEATS 14 0.0004
610 HAEMATEMESIS 11 0.0004
611 SEIZURE 50 0.0004
612 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
613 MUSCLE TIGHTNESS 7 0.0004
614 PLATELET COUNT DECREASED 46 0.0004
615 PULMONARY EMBOLISM 41 0.0004
616 HUNGER 6 0.0004
617 APHONIA 6 0.0004
618 POST PROCEDURAL HAEMORRHAGE 5 0.0004
619 THINKING ABNORMAL 8 0.0004
620 RENAL FAILURE 57 0.0004
621 BLOOD CREATININE INCREASED 28 0.0004
622 FATIGUE 333 0.0004
623 CHILLS 50 0.0004
624 RESPIRATORY FAILURE 31 0.0004
625 LEUKAEMIA 4 0.0004
626 ABDOMINAL DISCOMFORT 71 0.0004
627 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
628 CONSTIPATION 92 0.0004
629 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
630 BLOOD URINE PRESENT 8 0.0004
631 JOINT INJURY 9 0.0004
632 BRONCHOSPASM 6 0.0004
633 MYOCLONUS 5 0.0004
634 PULMONARY FIBROSIS 8 0.0004
635 SWELLING 39 0.0004
636 DEEP VEIN THROMBOSIS 27 0.0004
637 PRESCRIBED OVERDOSE 8 0.0004
638 ACUTE KIDNEY INJURY 63 0.0004
639 DEATH 352 0.0004
640 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
641 RESPIRATORY DEPRESSION 5 0.0004
642 BLINDNESS TRANSIENT 3 0.0004
643 BODY TEMPERATURE DECREASED 4 0.0004
644 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73 0.0004
645 WHEEZING 24 0.0004
646 BLADDER DISORDER 4 0.0004
647 COLON CANCER 6 0.0004
648 ILEUS 5 0.0004
649 UPPER LIMB FRACTURE 8 0.0004
650 DYSPEPSIA 39 0.0004
651 CORONARY ARTERY DISEASE 12 0.0004
652 MENTAL STATUS CHANGES 11 0.0004
653 ECONOMIC PROBLEM 6 0.0004
654 BRAIN OEDEMA 5 0.0004
655 CARDIAC DISORDER 37 0.0004
656 HYPOACUSIS 17 0.0004
657 VERTIGO 24 0.0004
658 DRY THROAT 4 0.0004
659 WOUND 11 0.0004
660 MOTOR DYSFUNCTION 4 0.0004
661 NEPHROLITHIASIS 18 0.0004
662 THERAPY INTERRUPTED 28 0.0004
663 ABDOMINAL PAIN 91 0.0004
664 DEPRESSION 89 0.0004
665 MUSCLE TWITCHING 9 0.0004
666 THYROID DISORDER 6 0.0004
667 HYPERHIDROSIS 50 0.0004
668 TEMPERATURE INTOLERANCE 4 0.0004
669 FEMUR FRACTURE 12 0.0004
670 SKIN ULCER 10 0.0004
671 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
672 VENTRICULAR EXTRASYSTOLES 4 0.0004
673 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
674 TENDERNESS 4 0.0004
675 LIVER DISORDER 17 0.0004
676 HERPES ZOSTER 22 0.0004
677 ROAD TRAFFIC ACCIDENT 16 0.0004
678 DERMATITIS 8 0.0004
679 TRANSFUSION 4 0.0004
680 HYPOAESTHESIA 57 0.0004
681 ANAPHYLACTIC REACTION 21 0.0004
682 TOOTH INFECTION 5 0.0004
683 ABDOMINAL PAIN UPPER 78 0.0004
684 JOINT DISLOCATION 4 0.0004
685 DISTURBANCE IN ATTENTION 20 0.0004
686 DECREASED ACTIVITY 4 0.0004
687 HYPOKALAEMIA 17 0.0004
688 SEROTONIN SYNDROME 7 0.0004
689 ABASIA 9 0.0004
690 INJECTION SITE NODULE 4 0.0004
691 GLAUCOMA 7 0.0004
692 DRUG INTOLERANCE 35 0.0004
693 HERNIA 7 0.0004
694 AGEUSIA 9 0.0004
695 VENTRICULAR FIBRILLATION 4 0.0004
696 SKIN DISORDER 12 0.0004
697 AGGRESSION 18 0.0004
698 CHOKING 7 0.0004
699 BACK PAIN 83 0.0004
700 WEIGHT INCREASED 80 0.0004
701 COMA 17 0.0004
702 RASH PAPULAR 8 0.0004
703 PRODUCT USE ISSUE 67 0.0004
704 ACCIDENTAL OVERDOSE 13 0.0004
705 DISABILITY 7 0.0004
706 ABNORMAL BEHAVIOUR 14 0.0004
707 MYOCARDIAL ISCHAEMIA 4 0.0004
708 MICTURITION URGENCY 4 0.0003
709 ANURIA 3 0.0003
710 SHOCK 8 0.0003
711 PRODUCT PHYSICAL ISSUE 7 0.0003
712 DRY MOUTH 28 0.0003
713 TASTE DISORDER 7 0.0003
714 HOT FLUSH 26 0.0003
715 APATHY 5 0.0003
716 GASTROENTERITIS 5 0.0003
717 COLD SWEAT 6 0.0003
718 LYMPHADENOPATHY 12 0.0003
719 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
720 ATAXIA 4 0.0003
721 ISCHAEMIC STROKE 6 0.0003
722 PAIN 206 0.0003
723 VISION BLURRED 46 0.0003
724 HAEMORRHAGE INTRACRANIAL 5 0.0003
725 RESPIRATORY DISORDER 10 0.0003
726 DRUG INTERACTION 53 0.0003
727 HYPOAESTHESIA ORAL 5 0.0003
728 LEUKOCYTOSIS 6 0.0003
729 RESTLESS LEGS SYNDROME 6 0.0003
730 BURSITIS 4 0.0003
731 SKIN LESION 9 0.0003
732 DEVICE MALFUNCTION 23 0.0003
733 INJURY 23 0.0003
734 EPILEPSY 10 0.0003
735 INSOMNIA 87 0.0003
736 TINNITUS 15 0.0003
737 DYSURIA 12 0.0003
738 SKIN CANCER 7 0.0003
739 ANAEMIA 62 0.0003
740 PHARYNGEAL OEDEMA 5 0.0003
741 FAECES DISCOLOURED 7 0.0003
742 CYST 4 0.0003
743 EXTRAPYRAMIDAL DISORDER 8 0.0003
744 MENTAL DISORDER 14 0.0003
745 MALAISE 141 0.0003
746 TOOTH EXTRACTION 4 0.0003
747 EXTRA DOSE ADMINISTERED 13 0.0003
748 ARTERIOSCLEROSIS 3 0.0003
749 MELAENA 7 0.0003
750 NIGHTMARE 11 0.0003
751 FRACTURE 6 0.0003
752 OSTEOPOROSIS 13 0.0003
753 CHRONIC KIDNEY DISEASE 24 0.0003
754 RED BLOOD CELL COUNT DECREASED 9 0.0003
755 VISUAL IMPAIRMENT 39 0.0003
756 HALLUCINATION, AUDITORY 5 0.0003
757 HEPATIC CYTOLYSIS 4 0.0003
758 HYPOTHYROIDISM 10 0.0003
759 MEMORY IMPAIRMENT 43 0.0003
760 INCORRECT DOSE ADMINISTERED 71 0.0003
761 MUSCLE SPASMS 57 0.0003
762 ERUCTATION 6 0.0003
763 RHINORRHOEA 20 0.0003
764 INJECTION SITE INDURATION 4 0.0003
765 DIPLOPIA 8 0.0003
766 BACK DISORDER 5 0.0003
767 NEUROPATHY PERIPHERAL 29 0.0003
768 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
769 DRUG LEVEL INCREASED 5 0.0003
770 HYPONATRAEMIA 17 0.0003
771 INFUSION RELATED REACTION 20 0.0003
772 CONDITION AGGRAVATED 91 0.0003
773 PARAESTHESIA 47 0.0003
774 LACRIMATION INCREASED 9 0.0003
775 SLEEP DISORDER 21 0.0003
776 FEAR 8 0.0003
777 FACE OEDEMA 5 0.0003
778 ILL-DEFINED DISORDER 18 0.0003
779 FREQUENT BOWEL MOVEMENTS 8 0.0003
780 HEMIPARESIS 5 0.0003
781 CIRCULATORY COLLAPSE 5 0.0003
782 INJECTION SITE WARMTH 6 0.0003
783 RESPIRATORY ARREST 8 0.0003
784 COLITIS 11 0.0003
785 PERITONITIS 6 0.0003
786 CEREBROVASCULAR ACCIDENT 49 0.0003
787 MENTAL IMPAIRMENT 7 0.0003
788 DIVERTICULITIS 8 0.0003
789 HAEMORRHAGE 30 0.0003
790 COORDINATION ABNORMAL 4 0.0003
791 PRODUCT USE IN UNAPPROVED INDICATION 71 0.0003
792 SKIN REACTION 4 0.0003
793 ARTHRALGIA 118 0.0003
794 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
795 IRRITABLE BOWEL SYNDROME 6 0.0003
796 BIPOLAR DISORDER 3 0.0003
797 BACK INJURY 3 0.0003
798 PRODUCT PRESCRIBING ISSUE 6 0.0003
799 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
800 PANIC ATTACK 10 0.0003
801 RENAL IMPAIRMENT 23 0.0003
802 SKIN EXFOLIATION 23 0.0003
803 ACUTE MYOCARDIAL INFARCTION 8 0.0003
804 LABORATORY TEST ABNORMAL 8 0.0003
805 DEVICE BREAKAGE 11 0.0003
806 EYE SWELLING 10 0.0003
807 PYREXIA 93 0.0003
808 ARTHRITIS 21 0.0003
809 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
810 GASTRITIS 7 0.0003
811 CONVULSION 15 0.0003
812 SWELLING FACE 17 0.0003
813 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
814 EYE IRRITATION 15 0.0003
815 EJECTION FRACTION DECREASED 4 0.0003
816 BURNING SENSATION 18 0.0003
817 HYPERKALAEMIA 9 0.0003
818 SWOLLEN TONGUE 8 0.0003
819 SKIN FISSURES 5 0.0003
820 INFLUENZA LIKE ILLNESS 21 0.0003
821 PRURITUS 97 0.0003
822 PROCEDURAL PAIN 7 0.0003
823 PNEUMOTHORAX 4 0.0003
824 ACCIDENT 3 0.0003
825 PRESCRIBED UNDERDOSE 5 0.0003
826 INJECTION SITE HAEMORRHAGE 20 0.0003
827 BLISTER 14 0.0002
828 ERYTHEMA 51 0.0002
829 ASTHMA 28 0.0002
830 HYPOGLYCAEMIA 12 0.0002
831 FIBROMYALGIA 6 0.0002
832 AMNESIA 16 0.0002
833 ADVERSE DRUG REACTION 22 0.0002
834 ENCEPHALOPATHY 6 0.0002
835 PRODUCT SUBSTITUTION ISSUE 14 0.0002
836 MANIA 4 0.0002
837 THROMBOCYTOPENIA 27 0.0002
838 NEEDLE ISSUE 7 0.0002
839 JOINT SWELLING 29 0.0002
840 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
841 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
842 ABDOMINAL PAIN LOWER 6 0.0002
843 OSTEOARTHRITIS 10 0.0002
844 INTENTIONAL OVERDOSE 15 0.0002
845 RECTAL HAEMORRHAGE 10 0.0002
846 HEPATIC FAILURE 7 0.0002
847 APHASIA 7 0.0002
848 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
849 SEDATION 6 0.0002
850 BLOOD GLUCOSE DECREASED 11 0.0002
851 DYSGEUSIA 17 0.0002
852 EMOTIONAL DISORDER 7 0.0002
853 DEVICE DIFFICULT TO USE 15 0.0002
854 LYMPHOCYTE COUNT DECREASED 4 0.0002
855 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
856 RASH 98 0.0002
857 CEREBRAL HAEMORRHAGE 8 0.0002
858 DRUG-INDUCED LIVER INJURY 7 0.0002
859 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
860 PAIN OF SKIN 6 0.0002
861 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
862 BONE PAIN 13 0.0002
863 OFF LABEL USE 194 0.0002
864 HYPERSENSITIVITY 41 0.0002
865 PALLOR 6 0.0002
866 MOOD ALTERED 6 0.0002
867 ABNORMAL DREAMS 6 0.0002
868 BLOOD GLUCOSE ABNORMAL 4 0.0002
869 HEPATIC STEATOSIS 4 0.0002
870 SUICIDE ATTEMPT 13 0.0002
871 STOMATITIS 13 0.0002
872 IMPAIRED HEALING 7 0.0002
873 TARDIVE DYSKINESIA 6 0.0002
874 MYALGIA 36 0.0002
875 PROTEINURIA 4 0.0002
876 INCREASED APPETITE 4 0.0002
877 URTICARIA 35 0.0002
878 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
879 CHOLESTASIS 4 0.0002
880 LIVER FUNCTION TEST ABNORMAL 6 0.0002
881 HEPATIC ENZYME INCREASED 14 0.0002
882 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
883 INJECTION SITE ERYTHEMA 25 0.0002
884 CATARACT 12 0.0002
885 ARTHROPATHY 11 0.0002
886 SKIN IRRITATION 9 0.0002
887 HEPATITIS 5 0.0002
888 ADVERSE EVENT 18 0.0002
889 DRY SKIN 26 0.0002
890 NEOPLASM MALIGNANT 13 0.0002
891 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
892 NERVOUSNESS 10 0.0002
893 INJECTION SITE BRUISING 15 0.0002
894 METABOLIC ACIDOSIS 6 0.0002
895 INTESTINAL OBSTRUCTION 7 0.0002
896 BLOOD BILIRUBIN INCREASED 5 0.0002
897 IRRITABILITY 11 0.0002
898 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
899 INJECTION SITE PRURITUS 12 0.0002
900 ORAL PAIN 4 0.0002
901 INFLAMMATION 9 0.0002
902 MYOCARDIAL INFARCTION 30 0.0002
903 EMOTIONAL DISTRESS 20 0.0002
904 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
905 RENAL FAILURE ACUTE 7 0.0002
906 CEREBRAL INFARCTION 4 0.0002
907 INJECTION SITE RASH 5 0.0002
908 INJECTION SITE MASS 6 0.0002
909 AGRANULOCYTOSIS 3 0.0002
910 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
911 PANCYTOPENIA 9 0.0002
912 HEPATIC FUNCTION ABNORMAL 6 0.0002
913 LEUKOPENIA 8 0.0002
914 INJECTION SITE PAIN 49 0.0002
915 DRUG INEFFECTIVE 208 0.0002
916 INJECTION SITE SWELLING 12 0.0002
917 ANAPHYLACTIC SHOCK 4 0.0002
918 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
919 MUSCULOSKELETAL PAIN 8 0.0002
920 EYE DISORDER 5 0.0002
921 DEPRESSED MOOD 8 0.0002
922 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
923 BLOOD CHOLESTEROL INCREASED 7 0.0002
924 EYE PRURITUS 5 0.0001
925 BLOOD GLUCOSE INCREASED 28 0.0001
926 THERAPEUTIC RESPONSE DECREASED 9 0.0001
927 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
928 OCULAR HYPERAEMIA 7 0.0001
929 PNEUMONITIS 4 0.0001
930 HAEMATURIA 5 0.0001
931 GASTRIC DISORDER 5 0.0001
932 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
933 INTERSTITIAL LUNG DISEASE 7 0.0001
934 RHABDOMYOLYSIS 6 0.0001
935 SUICIDAL IDEATION 13 0.0001
936 ANGINA PECTORIS 4 0.0001
937 THERAPY CESSATION 7 0.0001
938 ANGIOEDEMA 6 0.0001
939 RENAL INJURY 4 0.0001
940 OVERDOSE 29 0.0001
941 ECZEMA 7 0.0001
942 DERMATITIS ATOPIC 7 0.0001
943 PRODUCT QUALITY ISSUE 18 0.0001
944 ALOPECIA 26 0.0001
945 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
946 DISCOMFORT 8 0.0001
947 RASH PRURITIC 7 0.0001
948 NERVOUS SYSTEM DISORDER 4 0.0001
949 PLASMA CELL MYELOMA 5 0.0001
950 MULTIPLE SCLEROSIS 6 0.0001
951 LACTIC ACIDOSIS 4 0.0001
952 NEUTROPHIL COUNT DECREASED 5 0.0001
953 PRODUCT DOSE OMISSION 8 0.0001
954 CHOLELITHIASIS 4 0.0001
955 LUNG NEOPLASM MALIGNANT 5 0.0001
956 LIP SWELLING 4 0.0001
957 TYPE 2 DIABETES MELLITUS 4 0.0001
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
959 DISEASE PROGRESSION 14 0.0001
960 ANGER 4 0.0001
961 RHEUMATOID ARTHRITIS 13 0.0001
962 MYELOSUPPRESSION 4 0.0001
963 C-REACTIVE PROTEIN INCREASED 4 0.0001
964 HYPERGLYCAEMIA 4 0.0001
965 RASH ERYTHEMATOUS 5 0.0001
966 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
967 DRY EYE 5 0.0001
968 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
969 SKIN BURNING SENSATION 7 0.0001
970 UNDERDOSE 7 0.0001
971 WITHDRAWAL SYNDROME 4 0.0001
972 PANCREATITIS 5 0.0001
973 DIABETES MELLITUS 7 0.0001
974 INTENTIONAL PRODUCT MISUSE 8 0.0001
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
976 MEDICATION ERROR 5 0.0001
977 FEBRILE NEUTROPENIA 5 0.0001
978 ABORTION SPONTANEOUS 3 0.0001
979 TOXICITY TO VARIOUS AGENTS 12 0.0001
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
981 PRODUCT STORAGE ERROR 6 0.0001
982 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
983 NEUTROPENIA 9 0.0001
984 PROSTATE CANCER 5 0.0001
985 TREATMENT FAILURE 5 0.0001
986 INJECTION SITE REACTION 4 0.0001
987 DRUG WITHDRAWAL SYNDROME 5 0.0001
988 DRUG DOSE OMISSION 9 0.0001
989 NO ADVERSE EVENT 9 0.0000
990 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
991 PSORIASIS 4 0.0000